32 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease ... clinical manifestation ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... Preventing First ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
MDRO: Multiple Drug Resistant Organism (Stenehjem E et al. Clin Infect Dis. 2016; 63(10): 1273-1280)

#AntibioticClassificationSchema #Antibiotics
AntibioticClassificationSchema #Antibiotics ... #MDRO #clinical ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS Preventing ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Antibiotics for Intraabdominal Infection. 
Use your local antimicrobial susceptibility data for selecting the best empiric treatment!
Antibiotics for ... AAST 2021 global clinical ... #antibiogram #antibiotics ... infectiousdiseases #management ... #pharmacology #
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis #IDSA #Prevention ... opportunistic #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
prophylaxis for primary prevention ... Risk Factors • Clinical ... Presentation • Management ... #criticalcare #pharmacology ... #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology